Search Results
Sort by:
Filter 0
Sort by
17 April 2023 - P3453
Neuromyelitis optica mimicking isoniazid and ethambutol toxic optic neuropathy in a patient with tuberculous lymphadenitis
17 April 2023 - LB036
Evaluation of the efficacy and safety of a short-course, daily, four-month regimen including isoniazid, pyrazinamide, rifapentine and moxifloxacin (2HZPM/2HPM) for the treatment of drug-susceptible pulmonary tuberculosis in Taiwan (ESCAPE-TB)
15 April 2023 - P1112
Isoniazid mono-resistant tuberculosis: trends in a tertiary hospital in KwaZulu-Natal province, South Africa
15 April 2023 - P1091
Assessment of the incidence of active tuberculosis disease among people living with HIV/AIDS who took isoniazid preventive therapy
15 April 2023 - P1117
Prevalence of high level resistance to isoniazid and fluoroquinolones and their implication on empirical shorter DRTB regimen
15 April 2023 - P1120
Assessment of the magnitude and determinants of isoniazid preventive therapy uptake among under-five children in Addis Ababa, Ethiopia
15 April 2023 - P1125
Simultaneous detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis clinical isolates: performances of a rapid molecular assay
15 April 2023 - P1736
New diagnostic tests for direct detection of Mycobacterium tuberculosis complex, non-tuberculous mycobacteria and rifampicin/isoniazid resistance in clinical specimens from Norway
22 April 2022 - P1067
Comparative study of two commercial methods for genotypic detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin
10 July 2021 - 4392
Structural study of new katG mutations associated with isoniazid resistance selected in a murine model of Mycobacterium tuberculosis infection
14 April 2019 - O0929
Multi-centre study of the accuracy of the BD MAX MDR-TB assay for the detection of Mycobacterium tuberculosis complex and mutations associated with resistance to rifampin and isoniazid
14 April 2019 - O0931
Whole genome sequencing characterisation of isoniazid resistance mechanisms in Mycobacterium tuberculosis undetected by conventional molecular methods
13 April 2019 - P1024
MDR/MTB ELITe MGB kit: a quick and efficient solution for simultaneous research of MTB, isoniazid and rifampicin molecular resistance from extrapulmonary clinical samples
13 April 2019 - P1021
First evaluation of the new FluoroType MTBDR Version 2.0 assay for improved detection and differentiation of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex
13 April 2019 - P1002
Performance comparison of Xpert MTB/RIF Ultra and BD Max MDR-TB for rapid detection of Mycobacterium tuberculosis and its resistance to rifampicin and isoniazid in a country with a low incidence of multidrug-resistant tuberculosis
13 April 2019 - P1031
Evaluation of a microdilution method to analyze the activity of isoniazid, ethambutol and rifampicin at acid pH as a preliminary assessment to standardize the effect of drug combinations including pyrazinamide against Mycobacterium tuberculosis 
22 April 2018 - P1585A
Fully automated detection of MTB complex and Rifampicin/Isoniazid resistance with MDR/MTB ELITe MGB Kit and ELITe InGenius
22 April 2018 - P1561
Pre-validation of the BD Max MDR-TB assay for the rapid detection of MTBc DNA and mutations associated with rifampin and isoniazid resistance
Loading ...
+ load more
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.